日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O17:K52:H18 Pyrimidine-specific ribonucleoside hydrolase rihB (rihB) CSB-YP487079EOG
CSB-EP487079EOG
CSB-BP487079EOG
CSB-MP487079EOG
CSB-EP487079EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Periplasmic nitrate reductase (napA) CSB-YP487080EOG
CSB-EP487080EOG
CSB-BP487080EOG
CSB-MP487080EOG
CSB-EP487080EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Nucleoside triphosphatase nudI (nudI) CSB-YP487081EOG
CSB-EP487081EOG
CSB-BP487081EOG
CSB-MP487081EOG
CSB-EP487081EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE (arnE), partial CSB-YP487082EOG1
CSB-EP487082EOG1
CSB-BP487082EOG1
CSB-MP487082EOG1
CSB-EP487082EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP487083EOG
CSB-EP487083EOG
CSB-BP487083EOG
CSB-MP487083EOG
CSB-EP487083EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Erythronate-4-phosphate dehydrogenase (pdxB) CSB-YP487084EOG
CSB-EP487084EOG
CSB-BP487084EOG
CSB-MP487084EOG
CSB-EP487084EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Formyl-coenzyme A transferase (frc) CSB-YP487085EOG
CSB-EP487085EOG
CSB-BP487085EOG
CSB-MP487085EOG
CSB-EP487085EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Pyridoxine kinase (pdxK) CSB-YP487086EOG
CSB-EP487086EOG
CSB-BP487086EOG
CSB-MP487086EOG
CSB-EP487086EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 DnaA-homolog protein hda (hda) CSB-YP487087EOG
CSB-EP487087EOG
CSB-BP487087EOG
CSB-MP487087EOG
CSB-EP487087EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Cytoskeleton protein rodZ (rodZ), partial CSB-YP487088EOG
CSB-EP487088EOG
CSB-BP487088EOG
CSB-MP487088EOG
CSB-EP487088EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 HTH-type transcriptional regulator iscR (iscR) CSB-YP487089EOG
CSB-EP487089EOG
CSB-BP487089EOG
CSB-MP487089EOG
CSB-EP487089EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 tRNA (guanine-N (1)-)-methyltransferase CSB-YP487090EOG
CSB-EP487090EOG
CSB-BP487090EOG
CSB-MP487090EOG
CSB-EP487090EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Protein nrdI (nrdI) CSB-YP487091EOG
CSB-EP487091EOG
CSB-BP487091EOG
CSB-MP487091EOG
CSB-EP487091EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Nitric oxide reductase FlRd-NAD (+) reductase CSB-YP487092EOG
CSB-EP487092EOG
CSB-BP487092EOG
CSB-MP487092EOG
CSB-EP487092EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP487093EOG
CSB-EP487093EOG
CSB-BP487093EOG
CSB-MP487093EOG
CSB-EP487093EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Sulfite reductase [NADPH] hemoprotein beta-component (cysI) CSB-YP487094EOG
CSB-EP487094EOG
CSB-BP487094EOG
CSB-MP487094EOG
CSB-EP487094EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 L-fucose mutarotase (fucU) CSB-YP487095EOG
CSB-EP487095EOG
CSB-BP487095EOG
CSB-MP487095EOG
CSB-EP487095EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Bifunctional protein aas (aas), partial CSB-YP487096EOG1
CSB-EP487096EOG1
CSB-BP487096EOG1
CSB-MP487096EOG1
CSB-EP487096EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 D-erythrose-4-phosphate dehydrogenase (epd) CSB-YP487097EOG
CSB-EP487097EOG
CSB-BP487097EOG
CSB-MP487097EOG
CSB-EP487097EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Probable Fe (2+)-trafficking protein CSB-YP487098EOG
CSB-EP487098EOG
CSB-BP487098EOG
CSB-MP487098EOG
CSB-EP487098EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×